RecruitingPhase 1NCT07343245
A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics Drug-Drug Interaction of DW4421 and 3 NSAIDs in Healthy Adult Volunteers
Sponsor
Daewon Pharmaceutical Co., Ltd.
Enrollment
150 participants
Start Date
Dec 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Drug-Drug Interaction between DW4421 and three different kinds of NSAIDs
Eligibility
Min Age: 19 YearsMax Age: 50 Years
Inclusion Criteria2
- Healthy adult aged 19 to 50 (inclusive) years, at the time of screening.
- Subjects weighing between 50 kg and 90 kg with BMI between 18 and 27 kg/m2 (inclusive) at screening visit.
Exclusion Criteria1
- Those who have clinical significant liver, kidney, nervous system, respiratory, endocrine, hematology and oncology, cardiovascular, urinary, and mental diseases or past history
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDW4421
QD
DRUGDW4421-N1
BID
DRUGDW4421-N2
BID
DRUGDW4421-N3
QD
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07343245
Related Trials
Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
NCT076405551 location
A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects
NCT076336911 location
Modulation of Appetite Signaling Through Enterohormone Stimulation by DNF-10
NCT076213931 location
Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers
NCT076176881 location
Human Skin Safety Testing of 1 Mitopure Topical Product Using a Clinical Safety in Use Study in Healthy Volunteers
NCT075179001 location